Literature DB >> 3010596

Coronavirus IBV glycopolypeptides: locational studies using proteases and saponin, a membrane permeabilizer.

D Cavanagh, P J Davis, D J Pappin.   

Abstract

[35S]methionine-labelled avian infectious bronchitis virus (IBV) (strain 41) and its purified protein components and virions of IBV-Beaudette were incubated with 10 proteases. Several proteases hydrolysed all or some of the membrane glycopolypeptide (M; Mr 30K) and removed about 1.3K of peptide from the amino-(N-)-terminus plus both glycans, as determined by SDS-polyacrylamide gel electrophoresis. N-terminal analysis of [3H]isoleucine-labelled M after hydrolysis by bromelain revealed that the first nine residues had been removed. After the virions had been permeabilised with saponin, a further 2.5K decrease in molecular weight was produced and this was shown to be from the carboxy-(C-)terminus. When considered with the hydropathicity plot analysis of the amino acid sequence of M (Boursnell, M.E.G. et al., 1984, Virus Res. 1, 303-313) these results suggest that as few as 9-20 N-terminal amino acid residues may protrude at the outer membrane surface and that there is a highly protease sensitive sequence of an estimated 20-25 residues at the C-terminus of M exposed in the lumen of the virion. S2 but not S1 was cleaved to a major glycopolypeptide of approximately 71K by several proteases, and to 76K by trypsin. N-terminal sequencing of the 71K glycopolypeptide revealed that it had the same N-terminus as intact S2. After hydrolysis in the presence and absence of saponin it was concluded that S2 is very sensitive to hydrolysis near its carboxy terminus at residues close to the outer membrane surface.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010596      PMCID: PMC7134160          DOI: 10.1016/0168-1702(86)90038-9

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  19 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Coronavirus IBV: structural characterization of the spike protein.

Authors:  D Cavanagh
Journal:  J Gen Virol       Date:  1983-12       Impact factor: 3.891

3.  Coronavirus IBV: further evidence that the surface projections are associated with two glycopolypeptides.

Authors:  D Cavanagh
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

4.  Crystalline antigen from the influenza virus envelope.

Authors:  C M Brand; J J Skehel
Journal:  Nat New Biol       Date:  1972-08-02

5.  Cloning and sequencing of the gene encoding the spike protein of the coronavirus IBV.

Authors:  M M Binns; M E Boursnell; D Cavanagh; D J Pappin; T D Brown
Journal:  J Gen Virol       Date:  1985-04       Impact factor: 3.891

6.  Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins.

Authors:  D F Stern; B M Sefton
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

7.  Coronavirus proteins: biogenesis of avian infectious bronchitis virus virion proteins.

Authors:  D F Stern; B M Sefton
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

8.  Structural analysis of virion proteins of the avian coronavirus infectious bronchitis virus.

Authors:  D F Stern; L Burgess; B M Sefton
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

9.  Structural polypeptides of coronavirus IBV.

Authors:  D Cavanagh
Journal:  J Gen Virol       Date:  1981-03       Impact factor: 3.891

10.  Coronavirus IBV: partial amino terminal sequencing of spike polypeptide S2 identifies the sequence Arg-Arg-Phe-Arg-Arg at the cleavage site of the spike precursor propolypeptide of IBV strains Beaudette and M41.

Authors:  D Cavanagh; P J Davis; D J Pappin; M M Binns; M E Boursnell; T D Brown
Journal:  Virus Res       Date:  1986-02       Impact factor: 3.303

View more
  14 in total

Review 1.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

2.  Structural proteins of equine arteritis virus.

Authors:  A A de Vries; E D Chirnside; M C Horzinek; P J Rottier
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Identification of a novel linear B-cell epitope in the M protein of avian infectious bronchitis coronaviruses.

Authors:  Junji Xing; Shengwang Liu; Zongxi Han; Yuhao Shao; Huixin Li; Xiangang Kong
Journal:  J Microbiol       Date:  2009-10-24       Impact factor: 3.422

4.  Bioinformatics and evolutionary insight on the spike glycoprotein gene of QX-like and Massachusetts strains of infectious bronchitis virus.

Authors:  Shahid Hussain Abro; Karin Ullman; Sándor Belák; Claudia Baule
Journal:  Virol J       Date:  2012-09-19       Impact factor: 4.099

5.  A specific transmembrane domain of a coronavirus E1 glycoprotein is required for its retention in the Golgi region.

Authors:  C E Machamer; J K Rose
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

6.  Membrane association of the C-terminal half of the open reading frame 1a protein of lactate dehydrogenase-elevating virus.

Authors:  K S Faaberg; P G Plagemann
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 7.  The molecular biology of coronaviruses.

Authors:  M M Lai; D Cavanagh
Journal:  Adv Virus Res       Date:  1997       Impact factor: 9.937

8.  Identification of the structural proteins of turkey enteric coronavirus.

Authors:  S Dea; P Tijssen
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

9.  Comparison of four regions in the replicase gene of heterologous infectious bronchitis virus strains.

Authors:  Shankar P Mondal; Carol J Cardona
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

10.  Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus.

Authors:  J J Meulenberg; A Petersen-den Besten; E P De Kluyver; R J Moormann; W M Schaaper; G Wensvoort
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.